Besides, in lung cancer, Brognard and Dennis (2002) have pointed out the importance of ERK1/2 activation in NSCLC cell lines, where it promotes cell survival and chemotherapeutic resistance. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.